Mayne Pharma Group Ltd (MYX)

01/09/2022

Mayne Pharma Group Ltd (MYX)

Latest Reports

Afternoon report 22/10/2026

The Match Out: ASX slips on oil and inflation risks as Tech finds its footing

Local shares finished lower as higher oil prices and renewed rate-hike fears weighed on sentiment, with weakness across energy, materials, and consumer stocks. Despite a rebound in parts of the technology sector, concerns over data-centre funding and execution risks persisted, while a sharp retail profit warning underscored the pressure higher living costs and borrowing rates are placing on consumers.

Morning report 22/10/2026

What Matters Today: The digital marketplace stocks are fighting back

The ASX 200 experienced a choppy Wednesday before rallying into the close, finishing the day up +0.2% - not a bad performance, with BHP Group (-1.6%) and NEXTDC (-42%) combining to take almost 26 points off the index. Fortunately, the banks provided a rare bright spot, with Morgan Stanley estimating that NAB’s planned cull of 2,500 roles could deliver annual cost savings of $400–500 million.